Hans Wedel
Hans Wedel publishes mostly in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery, on topics such as Blood Pressure and Hypertension Studies, Lipoproteins and Cardiovascular Health and Heart Failure Treatment and Management.
- World rank
- #21,999 of 7,710,434 ranked researchers
- Rank in Sweden
- #116 of 71,437
- Works
- 343
- Citations
- 75k
- Citations per work
- 218.6
What does Hans Wedel research?
Hans Wedel's work is mostly in Medicine (63%), Health Professions (4%), Economics, Econometrics and Finance (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences23067.0%
- Medicine21763.4%
- Health Professions123.6%
- Everything else10430.3%
- Social Sciences92.7%
- 1Cardiology and Cardiovascular Medicine34% of their works
- 2Endocrinology, Diabetes and Metabolism14% of their works
- 3Surgery11% of their works
- 4Public Health, Environmental and Occupational Health4% of their works
- 5General Health Professions4% of their works
- 6Economics and Econometrics3% of their works
Research topics
- Blood Pressure and Hypertension Studies
- Lipoproteins and Cardiovascular Health
- Heart Failure Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiovascular Function and Risk Factors
- Acute Myocardial Infarction Research
- Diabetes Treatment and Management
- Hormonal Regulation and Hypertension
Which keywords describe Hans Wedel's research?
The keywords of their largest research topics: Cardiovascular Disease, Heart Failure, Clinical Guidelines, Cardiovascular Events, Hypertension, Guidelines, Obesity and Antihypertensive Drugs.
- Primary Aldosteronism
- Type 2 Diabetes
- Myocardial Infarction
- Echocardiography
- Insulin Resistance
- Treatment
- Statins
- Metabolic Syndrome
- Antihypertensive Drugs
- Guidelines
- Cardiovascular Events
- Heart Failure
- Cardiovascular Disease
- Clinical Guidelines
- Hypertension
- Obesity
- Blood Pressure
- Cholesterol-lowering
- Diagnosis
- Diabetes
- Chamber Quantification
- Acute Coronary Syndromes
- Cardiovascular Outcomes
- Aldosterone
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Cardiovascular Disease1974 topics
- Heart Failure1103 topics
- Clinical Guidelines922 topics
- Cardiovascular Events862 topics
- Hypertension862 topics
- Guidelines842 topics
- Obesity772 topics
- Antihypertensive Drugs671 topic
- Blood Pressure671 topic
- Metabolic Syndrome652 topics
- Cholesterol-lowering601 topic
- Statins601 topic
- Diagnosis541 topic
- Treatment541 topic
- Diabetes461 topic
- Insulin Resistance461 topic
- Chamber Quantification311 topic
- Echocardiography311 topic
- Acute Coronary Syndromes301 topic
- Myocardial Infarction301 topic
- Cardiovascular Outcomes251 topic
- Type 2 Diabetes251 topic
- Aldosterone191 topic
- Primary Aldosteronism191 topic
Where does Hans Wedel work?
Hans Wedel's main affiliation in the publication record is Nordic School of Public Health, Sweden.
How many publications and citations does Hans Wedel have?
OpenAlex counts 343 works and 74,989 citations for Hans Wedel, an h-index of 103, ranking #21,999 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hans Wedel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.